[an error occurred while processing this directive]

Study on biosafety of dialyzer

  • XU Jian-Xia ,
  • HAO Qing ,
  • LIU Kang-Bo ,
  • ZHAO Dan-Mei ,
  • WANG Xue-Ying ,
  • LIU Zi-Qi ,
  • FU Bu-Fang
Expand
  • National Institute for Food and Drug Control, Beijing 102629, China; 2Henan Institute for Drug and Medical Device Inspection (Henan Vaccine Issuance Center), Zhengzhou 450018, China

Received date: 2024-10-10

  Revised date: 2025-06-25

  Online published: 2025-09-12

Abstract

bjective To establish effective methods for detecting hazardous substances in dialyzers. Method  The industry-standard of hemolysis test and reducing substance assay were optimized: ①the contact time between hollow fibers and red blood cells was prolonged and a dynamic, back-and-forth sliding motion of the fibers in the erythrocyte suspension was introduced; ②the entire dialyzer was exhaustively extracted and, after extraction, fully obtain all the extraction solutions to determine the total amount of reducing substances in the device. The hemolysis rate and reducing substance content of 16 batches of dialyzers were tested by both the standard and optimized protocols; results were compared. After further refinement, the optimized methods were applied to 28 additional  batches of dialyzers to determine hemolysis rate and total reducing substances and to analyze their correlation. In addition, relevant studies on the wavelength band of the maximum absorption peak of the dialyzer extract and the appropriateness of the current extract-collection protocol in biological experiments were also conducted.  Result  The optimized hemolysis test (t=-5.987, P< 0.001) and reducing substance content (t=-4.601, P <0.001) assay demonstrated higher sensitivity than the standard protocols. With the standard methods, hemolysis rate and reducing substance content levels of the 16 batches of dialyzers were uniformly low; with the optimized methods, hemolysis rate ranged from 0.5 % to 12.2 %, and total reducing substances from 3.8 mL to 90.4 mL. For the 28 batches of dialyzers, hemolysis rate correlated positively with total reducing substances (r=0.478, P=0.013); when total reducing substances exceeded 30 mL, hemolysis rate was ≥5 %. The dialyzer extract showed maximum UV absorbance at 200 nm. After obtaining extract liquid in the common way, a substantial volume of fluid remained inside the hollow fibers.   Conclusion  ①The optimized methods for the reducing substances content and hemolysis rate are effective for quantifying hazardous components. Controlling the total amount of reducing substances can, to a certain extent, achieve the goal of limiting the content of hazardous substances.  ② Industry standard YY0053 needs to be revised: the reducing substance assay and hemolysis rate test should be tightened according to the optimized protocols mentioned in our study. the UV absorbance wavelength should be corrected; and the      extraction procedure for biological tests should specify complete removal of residual fluid from the dialyzer using repeated vacuumassisted aspiration.

Cite this article

XU Jian-Xia , HAO Qing , LIU Kang-Bo , ZHAO Dan-Mei , WANG Xue-Ying , LIU Zi-Qi , FU Bu-Fang . Study on biosafety of dialyzer[J]. Chinese Journal of Blood Purification, 2025 , 24(09) : 746 -752 . DOI: 10.3969/j.issn.1671-4091.2025.09.006

References

[1] Haq Z , Wang X , Cheng Q ,et al.Bisphenol A and Bisphenol S in Hemodialyzers.[J].Toxins, 2023, 15 7.DOI:10.3390/toxins15070465.
[2] Badding M A , Vargas J R , Fortney J ,et al.Toxicological risk assessment of bisphenol a released from dialyzers under simulated-use and exaggerated extraction conditions[J].Regulatory toxicology and pharmacology : RTP, 2020, 118:104787.DOI:10.1016/j.yrtph.2020.104787.
[3]Aranzazu Rodríguez-Sanz,Rafael Sánchez-Villanueva,Javier Domínguez-Ortega,et al.Mechanisms Involved in Hypersensitivity Reactions to Polysulfone Hemodialysis Membranes[J].Artificial Organs, 2017, 41(11).DOI:10.1111/aor.12954.
[4] Yao Q , Axelsson J , Stenvinkel P ,et al.Chronic systemic inflammation in dialysis patients: an update on causes and consequences.[J].Asaio Journal, 2004, 50(6):lii-lvii.DOI:10.1097/01.MAT.0000147958.87989.EB.
[5] Zhang J , Hua G , Zhang X ,et al.Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events.[J].Nephrology, 2010, 15(1):33-41.DOI:10.1111/j.1440-1797.2009.01172.x.
[6] Kario K , Matsuo T , Kobayashi H ,et al.High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction[J].Thrombosis & Haemostasis, 1995, 74(4):1020-1024.DOI:10.1055/s-0038-1649872.
[7] YY 0053-2008,心血管植入物和人工器官 血液透析器,血液透析滤过器,血液滤过器和血液浓缩器[S].
[8] GB/T 16886.1-2022 医疗器械生物学评价 第1部分:风险管理中的评价与试验
[9] GB 8368-2018 一次性使用输液器 重力输液式
[10] GB/T 16886.4-2022医疗器械生物学评价 第4部分:与血液相互作用试验选择
[11] ISO 10993.1-2018 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
[12]许建霞,付步芳,付海洋.透析器溶血试验方法改进研究[J].中国血液净化, 2023, 22(1):36-39.
[13] YY/T 1920 透析器血液相容性试验
[14] National Institutes of Health. Evaluation of hemodialyzers and dialysis membranes. Report of a Study Group for the Artificial Kidney-Chronic Uremia Program NIAMDD-1977. Chapter two. In vitro characterization of hemodialyzers. ArtifOrgans 1977;1(2):59-77.
[15] ASTM F567-17 Standard Practice for Assessment of Hemolytic Properties of Materials
[16] Ministry of Health, Labour and Welfare (MHLW), Japan: Testing Methods to Evaluate Biological Safety of Medical Devices, Notice from the office medical devices evaluation number 36,2003
[17] GB/T 16175-2008 医用有机硅材料生物学评价试验方法
[18] GB/T 14233.2-2005 医用输液、输血、注射器具检验方法 第2部分:生物学试验方法
[19]王兆星,史振伟.血液透析患者的双酚A暴露情况及潜在危害[J].中国血液净化, 2020, 19(1):3.DOI:CNKI:SUN:ZGJH.0.2020-01-020.
Options
Outlines

/

[an error occurred while processing this directive]